A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment
DOI:
https://doi.org/10.54097/5crj2x50Keywords:
CRISPR/cas9, Disease treatment, Mechanism, Challenges.Abstract
The appearance of CRISPR/Cas9 gene editing technology marks a revolutionary advance in the field of gene editing. With its high degree of specificity and efficiency, this technology enables precise modification of genome-specific loci. This paper reviews the mechanism of CRISPR/Cas9 and its applications in various fields such as genetic disease treatment, cancer therapy, antiviral therapy, gene function research and virus detection. Also, the challenges of off-target effects are discussed and strategies to minimize them are proposed, The purpose of this study is to propose applications and innovations of CRISPR/Cas9 technology in medical therapeutics while addressing its current limitations.
Downloads
References
[1] Pang, Z., Guan, Y., Sun, J., & Wang, Y. (2022). Advances in the development and application of CRISPR/Cas9 gene editing tools. *Biochemical Engineering*, (5), 140-148.
[2] Wang, L., & Zhao, T. (2017). The principle of CRISPR/Cas9 and its research progress in disease treatment. *Developmental Medicine Electronic Journal*, (1), 35-44.
[3] Huang, J., & Fang, S. (2024). Advances in molecular diagnostics applications based on the CRISPR-Cas system. *Journal of Molecular Diagnostics and Therapy*, (6), 989-992+1001. https://doi.org/10.19930/j.cnki.jmdt.2024.06.004
[4] Wu, C., & Wang, D. (2024). A new era in disease treatment led by CRISPR/Cas9. *Biology Teaching*, (1), 7-10.
[5] Chen, M., Mao, A., Xu, M., Weng, Q., Mao, J., & Ji, J. (2019). CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Cancer letters, 447, 48–55. https://doi.org/10.1016/j.canlet.2019.01.017
[6] Savić, N., & Schwank, G. (2016). Advances in therapeutic CRISPR/Cas9 genome editing. Translational research : the journal of laboratory and clinical medicine, 168, 15–21. https://doi.org/10.1016/j.trsl.2015.09.008
[7] Wang, S. W., Gao, C., Zheng, Y. M., Yi, L., Lu, J. C., Huang, X. Y., Cai, J. B., Zhang, P. F., Cui, Y. H., & Ke, A. W. (2022). Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Molecular cancer, 21(1), 57. https://doi.org/10.1186/s12943-022-01518-8
[8] Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., Virgin, H. W., Listgarten, J., & Root, D. E. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature biotechnology, 34(2), 184–191. https://doi.org/10.1038/nbt.3437
[9] Xiao, Q., Guo, D., & Chen, S. (2019). Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy. Frontiers in cellular and infection microbiology, 9, 69. https://doi.org/10.3389/fcimb.2019.00069
[10] Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013). Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Scientific reports, 3, 2510. https://doi.org/10.1038/srep02510
[11] Tabebordbar M, Zhu K, Cheng JK, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells［J］. Science, 2016, 351(6271): 407-411.
[12] ROTHGANGL T,DENNIS M K,LIN P J C,et al.In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels[J].Nat Biotechnol,2021,39(8):949-957.
[13] Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr, Butel, J. S., & Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356(6366), 215–221. https://doi.org/10.1038/356215a0
[14] Joung, J., Ladha, A., Saito, M., Segel, M., Bruneau, R., Huang, M. W., Kim, N. G., Yu, X., Li, J., Walker, B. D., Greninger, A. L., Jerome, K. R., Gootenberg, J. S., Abudayyeh, O. O., & Zhang, F. (2020). Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv : the preprint server for health sciences, 2020.05.04.20091231. https://doi.org/10.1101/2020.05.04.20091231
[15] Gootenberg, J. S., Abudayyeh, O. O., Kellner, M. J., Joung, J., Collins, J. J., & Zhang, F. (2018). Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science (New York, N.Y.), 360(6387), 439–444. https://doi.org/10.1126/science.aaq0179
[16] Rupp, L. J., Schumann, K., Roybal, K. T., Gate, R. E., Ye, C. J., Lim, W. A., & Marson, A. (2017). CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells. Scientific reports, 7(1), 737. https://doi.org/10.1038/s41598-017-00462-8
[17] Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M. (2015). Identification and characterization of essential genes in the human genome. Science (New York, N.Y.), 350(6264), 1096–1101. https://doi.org/10.1126/science.aac7041
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Academic Journal of Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
